Anxiety disorders collectively represent the most prevalent mental health condition in the United States — affecting more than 40 million adults — and yet conventional treatments leave a significant fraction of patients with persistent, impairing symptoms that antidepressants and therapy have not adequately addressed. At KDI Health in Frisco, TX, we work with patients whose anxiety — whether generalized anxiety disorder, social anxiety, panic disorder, or anxiety intertwined with depression and PTSD — has not responded sufficiently to first-line care. IV and IM ketamine therapy represent off-label options that, for a meaningful portion of these patients, offer relief that they could not find elsewhere.
Why Ketamine May Help Anxiety: The Neurobiological Mechanism
The neurobiological story behind ketamine and anxiety is closely linked to its better-known antidepressant mechanism. Anxiety disorders, like depression, involve dysfunction in glutamatergic signaling and reduced synaptic density in prefrontal cortical regions that regulate the threat response generated by the amygdala. Ketamine’s NMDA receptor antagonism promotes rapid synaptogenesis in the prefrontal cortex — rebuilding the very connections that chronic anxiety erodes — which may restore the top-down regulatory capacity over fear circuitry that anxiety disorders undermine. Published research in journals including the Journal of Psychiatric Research has documented significant reductions in anxiety symptoms following ketamine administration, particularly in patients whose anxiety co-occurs with depression.
What the Clinical Evidence Actually Shows
We want to be precise about the evidence state. The clinical trial data for ketamine in anxiety-specific populations is less robust than for treatment-resistant depression. Most of the published evidence comes from patients with comorbid anxiety and depression, which represents the majority of the anxiety patients we see clinically but is not identical to pure anxiety presentations. We discuss this distinction transparently in every anxiety consultation, and we do not overstate what the evidence supports. What we do say clearly is that a plausible mechanism exists, early evidence supports it, and for patients who have not found adequate relief through conventional care, the evidence profile is strong enough to warrant a serious discussion.
Physician-Supervised Ketamine for Anxiety at KDI Health in Frisco, TX
Dr. Stephen Gasper, founder and medical director of KDI Health, brings a specific orientation to anxiety treatment that stems from his background. Having served in the Marines as a forward observer in the infantry and spent over a decade as an emergency physician, he understands both acute and chronic forms of threat-state dysregulation — and he approaches anxiety treatment with both clinical precision and personal understanding. Our practice model — one patient at a time, direct physician oversight throughout every session — is particularly relevant for anxiety patients, who benefit from the security of knowing that the physician is present and attentive throughout the entire infusion. Learn more about IV ketamine treatment infusions and what to expect during your sessions.
Managing the In-Session Experience for Anxiety Patients
The barrier we hear most frequently from anxiety patients is fear of the dissociative experience itself. Patients with anxiety, by definition, often have a difficult relationship with uncertainty, altered states, and perceived loss of control. The prospect of a forty-minute period of dissociation can feel deeply threatening rather than therapeutic. This is something we take seriously and prepare for explicitly. Our pre-infusion process with anxiety patients is thorough: we explain in detail what the session will involve, discuss how to work with rather than against the altered state, and help patients develop a relationship with the experience that emphasizes curiosity over resistance. Dr. Gasper is present throughout, and patients can hear his voice and receive grounding at any point. Results vary by individual — some anxiety patients find the experience too distressing to continue, and we support that outcome without pressure.
Cost, Comorbid Conditions, and the Full Clinical Picture
The second barrier is the familiar question of cost. Like all ketamine therapy for psychiatric indications at KDI Health, IV and IM ketamine for anxiety is typically not covered by commercial insurance. We discuss the full cost of treatment openly during the consultation process and do not obscure what a full series involves financially. For patients whose anxiety is the primary barrier to functioning — their jobs, relationships, and quality of life — the calculus of cost versus benefit is one we encourage them to think through carefully and honestly with us and with their existing providers.
For patients whose anxiety co-occurs with PTSD, which is common in the veteran and first-responder community that forms a significant part of our patient population at KDI Health, ketamine’s dual effect on both conditions may offer particular clinical value. Similarly, for patients whose anxiety is accompanied by treatment-resistant depression, SPRAVATO® (esketamine) may be a relevant option to explore for the depressive component. We consider the full diagnostic picture during every consultation and do not treat anxiety in isolation if there are comorbid conditions that warrant consideration.
Frequently Asked Questions
Is ketamine FDA-approved for anxiety disorders?
No. Ketamine’s use for anxiety is off-label. The FDA approval for ketamine is limited to anesthesia. Ketamine for psychiatric conditions including anxiety is an off-label application supported by emerging research but not approved by the FDA for those indications. Discuss your specific situation with your provider.
Is there evidence that ketamine helps anxiety specifically?
Yes, though the evidence is more developed for anxiety comorbid with depression than for pure anxiety presentations. Research in journals including the Journal of Psychiatric Research supports meaningful anxiety symptom reduction following ketamine in these populations. Results vary by individual.
Can patients with anxiety tolerate the ketamine experience?
Many can, with appropriate preparation. Our pre-infusion process for anxiety patients is specifically designed to address the relationship between anxiety and altered states. Dr. Gasper is present throughout every session. Some patients do not tolerate the dissociative experience, which is a valid outcome.
Does KDI Health offer IM ketamine for anxiety?
Yes. Both IV and IM ketamine are available. Some anxiety patients prefer the somewhat gentler onset profile of IM delivery. Dr. Gasper evaluates which format is most appropriate during your consultation.
How does ketamine for anxiety fit with my current therapy or medication?
We encourage patients to maintain existing therapeutic relationships. Ketamine may enhance the effectiveness of ongoing therapy, particularly during the neuroplasticity window following infusions. We review your current medications for potential interactions during the consultation. For a broader perspective on combining approaches, see our post on the benefits of psychotherapy for managing anxiety and depression.
Key Takeaways
- Ketamine for anxiety disorders is an off-label treatment with growing evidence, particularly for anxiety co-occurring with depression and PTSD.
- Ketamine’s prefrontal synaptogenesis mechanism addresses the neurobiological basis of anxiety disorders, not just symptom suppression.
- KDI Health’s one-patient-at-a-time model with direct physician presence is particularly relevant for anxiety patients who may be sensitive to the altered state experience.
- Pre-infusion preparation for anxiety patients is specifically designed to address dissociation-related concerns.
- Results vary by individual; thorough consultation and honest expectations are essential.
Anxiety that does not respond to standard treatment is not a character flaw — it is a biological problem that deserves a biological solution proportionate to its severity. At KDI Health in Frisco, TX, we take that seriously and bring clinical precision, physician presence, and genuine understanding to every patient we see. Schedule a consultation and discuss whether IV or IM ketamine therapy may be a meaningful next step in your care. Always review your full clinical picture with your provider before making any treatment decisions.
About Dr. Stephen Gasper
Dr. Stephen Gasper is the owner and medical director of KDI Health Ketamine Clinic, which he founded in early 2021 in Frisco, TX. At the age of 17, he enlisted in the Marines, serving four years as a forward observer in the infantry. He then moved to Texas and obtained his BS in Biology from the University of Dallas. Dr. Gasper received his Medical Degree from UTHealth Houston in 2011 and practiced medicine in the DFW area for over 10 years as a board-certified Emergency Physician. He was inspired to found KDI Health during the COVID pandemic because of the effectiveness of ketamine as a therapy for veterans and the broader community struggling with depression, anxiety, and PTSD. Dr. Gasper personally oversees every session administered at the clinic and sees one patient at a time, providing direct physician oversight throughout each treatment.
References
Anxiety and Depression Association of America — Anxiety Statistics: https://adaa.org/understanding-anxiety
Journal of Psychiatric Research — Ketamine and Anxiety Evidence: https://www.journals.elsevier.com/journal-of-psychiatric-research
National Institute of Mental Health — Anxiety Disorders: https://www.nimh.nih.gov/health/topics/anxiety-disorders
American Psychiatric Association — Anxiety Disorders: https://www.psychiatry.org/patients-families/anxiety-disorders
American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3): https://www.askp3.org/
Medical Disclaimer
The content on this page is provided by KDI Health for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine’s use for anxiety disorders is off-label. Individual results vary. This content does not replace evaluation by a qualified psychiatric or medical provider. Always discuss your health history, current medications, and treatment options with a licensed professional before making any medical decisions. If you are experiencing a mental health crisis, please call or text 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.
